GLP-1 Drugs Show 30% Lower Breast Cancer Risk in Major Study
Large observational study finds women taking GLP-1 drugs like Ozempic and Wegovy show 30% lower breast cancer rates. Clinical trials…
Editor's Top Picks
Novel PET Tracer Detects Blood Clots in Legs and Lungs with Single Scan
Novel PET radiotracer enables simultaneous detection of deep vein thrombosis and pulmonary embolism in single whole-body scan. Research recognized with…
Submit Your Paper to GMJ
UK Trade Deal to Raise NHS Drug Costs Faces Legal Challenge from Patient Groups
The UK government's plan to raise the price the NHS pays for drugs by adjusting NICE's cost-effectiveness threshold has triggered…
Inhaled Treprostinil Shows Promise in Advanced Pulmonary Fibrosis: Phase 3 Trial Results
A phase 3 clinical trial published in The New England Journal of Medicine shows that inhaled treprostinil reduces the decline…
RTS,S Malaria Vaccine’s Antibody Fingerprint Reveals Key to Improved Protection in African Children
Post hoc analysis of the RTS,S malaria vaccine trial reveals that children with high antibody responses to specific epitopes (NANP2…
First-Trimester NSAIDs and Birth Defects: Large Cohort Study Finds No Increased Risk
A population-based cohort study of 54,000 pregnancies found no increased risk of major congenital malformations associated with first-trimester NSAID exposure,…
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight and metabolic health applications. The…
TrumpRx Expands Generic Drug Portfolio Through Amazon Pharmacy and GoodRx Partnership
TrumpRx has partnered with Amazon Pharmacy and GoodRx to expand into generic medications, signaling a major shift in its pharmaceutical…
New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency
A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…
New treatment approach offers hope for pre-eclampsia, a leading cause of maternal death
Pre-eclampsia causes more than 70,000 maternal deaths annually worldwide. Researchers are now investigating novel therapeutic approaches targeting placental dysfunction and…